Search
Now showing items 1-10 of 15
Predictors of unknown HIV serostatus at the time of labor and delivery in Kampala, Uganda.
(Elsevier Ireland, 2013)
Objective: To determine factors associated with an unknown HIV serostatus among pregnantwomen admitted in
labor to Mulago Hospital, Kampala, Uganda. Methods: In total, 665 pregnant women admitted to Mulago Hospital
were ...
In vivo PPD reactivity and associated factors among HIV positive patients on HAART at the Makerere University Infectious Diseases Clinic.
(2009-08)
BACKGROUND:
It is estimated that a third of the world’s population is infected with tuberculosis (TB).
This epidemic is fueled by HIV, with reactivation rates of 8-10% / year and overall lifetime risk of 30% in HIV ...
VS411 Reduced immune activation and HIV-1 RNA levels in 28 days: randomized proof-of-concept study for antiviral-hyperactivation limiting therapeutics
(PLoS One, 2012)
Background: A new class of antiretrovirals, AntiViral-HyperActivation Limiting Therapeutics (AV-HALTs), has been proposed as a disease-modifying therapy to both reduce Human Immunodeficiency Virus Type 1 (HIV-1) RNA levels ...
Dissertation barriers to timely initiation of antiretroviral therapy among HIV infected children admitted to mulago hospital paediatric wards.
(2007-08)
BACKGROUND:
The median survival of HIV infected children in the absence of treatment is 2 years, thus early initiation of ART is desirable.
In Uganda, ART is now being provided free of charge. However, some children still ...
The effect of Aids defining conditions on immunological recovery among patients initiating antiretroviral therapy at JCRC, Kampala, Uganda
(2008-10)
BACKGROUND:
During 2005, the world health organization (WHO) estimated that there were over 1.3 million people receiving antiretroviral therapy (ART). As the number of individuals able to access treatment is ever increasing, ...
Prevalence, pattern and factors associated with liver enzyme elevation among HIV-infected patients admitted in Kiruddu National Referral Hospital
(Makerere University, 2022-12-18)
Background: Globally, mortality and morbidity among Human Immunodeficiency Virus (HIV)-infected patients have tremendously improved over the years in this post- Highly Active Anti-retroviral Therapy (HAART) era. However, ...
Low-level viraemia: An emerging concern among people living with HIV in Uganda and across sub-Saharan Africa
(AOSIS, 2022)
Attaining viral load (VL) suppression for over 95% of the people living with HIV on antiretroviral therapy is a fundamental step in enabling Uganda and other sub-Saharan African countries to achieve global Sustainable ...
Suspected adverse drug reactions of isoniazid preventive therapy in HIV-positive patients at three regional hospitals: prevalence, associated factors, management and reporting
(Makerere University, 2021-11)
Background
Tuberculosis (TB) is the 10th leading cause of death globally and the leading cause of death from a single infectious agent among people living with HIV (PLHIV). Uganda is among the 30 high burden TB countries ...
Prevalence and factors associated with dyslipidemia among adult patients on dolutegravir based antiretroviral regimen at Mengo Hospital, A cross-sectional study
(Makerere University, 2022-12)
Introduction: Dolutegravir (DTG) based anti-retroviral therapy (ART) regimen has been rolled out in Uganda as the preferred first- and second-line treatment option in the management of Human Immunodeficiency Virus (HIV). ...
HIV viral load suppression and associated factors among people with mental disorders at Butabika Hospital and Mulago ISS Clinics: A mixed methods study
(Makerere University, 2022-12)
INTRODUCTION
In 2017 Uganda adopted the universal test and treat (UTT) guidelines. According to the UTT guidelines, people who test positive for HIV should be immediately initiated on antiretroviral therapy (ART) regardless ...